Clinical Outcomes of Patients with a Light Adjustable Lens (LAL) in At Least One Eye

Completed

• Conditions: IOL
• Interventions: Device: Light Adjustable Lens

• Registration Number: NCT06016231
• Lead Sponsor: Bucci Laser Vision Institute

Brief Summary

To collect data on bilateral pseudophakic patients implanted with the RxSight Light Adjustable Lens (LAL) in at least one eye

Detailed Description

Not available

Study Timeline

• Status Verified: 2023-08
• Study Start: 2023-08-15
• Study First Submitted: 2023-08-17
• Study First Submitted QC: 2023-08-23
• Study First Posted: 2023-08-29
• Primary Completion: 2023-12-31
• Study Completion: 2023-12-31
• Last Update Submitted: 2024-10-18
• Last Update Posted: 2024-10-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

• Adults with bilateral pseudophakia who have been implanted with the LAL in at least one eye and who have completed LDD light treatments

Exclusion Criteria

• Visually significant eye disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
LAL in at least one eye	Light Adjustable Lens	-

Primary Outcome Measures

Name	Time	Method
Patient Satisfaction - subjective questionnaire	3-18 months after cataract surgery	Subjective questionnaire explores the frequency/need for glasses for various visual functions at distance/intermediate/near, experience with dysphotopsias, and overall satisfaction of visual function without glasses.

Trial Locations

Locations (1)

Bucci Laser Vision Institute; 🇺🇸 Wilkes-Barre, Pennsylvania, United States